NCT04130997Phase 3Active not recruiting

An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis

Study sponsor: TG Therapeutics, Inc. · TGTX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2032-05-31Estimated

Enrollment · participants1100Estimated

Source updated2026-09-23Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-03 · 1 field changed

Primary completion date changed

− Before

~~1 Feb 2030~~

+ After

31 May 2032

Check registry source